CVNA insider plans sale of 30,952 shares worth $12.37M

CVNA insider Thomas Taira has filed a notice of proposed sales of up to 30,952 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 12,373,681.04.

Rhea-AI Filing Summary

CVNA insider Thomas Taira has filed a notice of proposed sales of up to 30,952 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 12,373,681.04. The filing reports that 141,423,193 common shares were outstanding.

The shares to be sold come from two sources: 20,000 shares acquired on 12/08/2025 through a cash exercise of stock options, and 10,952 shares from restricted and performance stock units granted on 07/19/2023. The notice also lists prior Rule 10b5-1 sales over the past three months, including 25,000 shares sold on 12/03/2025 for gross proceeds of 10,000,000.00, 10,000 shares on 11/28/2025 for 3,750,126.00, and 952 shares on 11/10/2025 for 309,400.00.

FAQ

What does the Form 144 filing for CVNA disclose?

The Form 144 discloses that Thomas Taira plans to sell up to 30,952 shares of CVNA common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 12,373,681.04.

How many CVNA shares are planned to be sold and what is their value?

The filing reports a planned sale of 30,952 CVNA common shares, with an aggregate market value of 12,373,681.04.

How were the CVNA shares in this Form 144 acquired?

According to the filing, 20,000 shares were acquired on 12/08/2025 via a cash exercise of stock options, and 10,952 shares were acquired as restricted and performance stock units on 07/19/2023.

What prior CVNA share sales does the insider report in the last 3 months?

The insider lists Rule 10b5-1 sales of 25,000 shares on 12/03/2025 for 10,000,000.00, 10,000 shares on 11/28/2025 for 3,750,126.00, and 952 shares on 11/10/2025 for 309,400.00.

How many CVNA shares are reported as outstanding in this filing?

The filing states that there are 141,423,193 CVNA common shares outstanding.

Which broker is handling the planned CVNA share sale in this Form 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001607889
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CARVANA CO
SEC File Number	001-38073
Address of Issuer	300 E. Rio Salado Parkway Tempe ARIZONA 85281
Phone	6029229866
Name of Person for Whose Account the Securities are To Be Sold	THOMAS TAIRA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30952	12373681.04	141423193	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2025	Exercise of Stock Options	Issuer			20000	12/08/2025	Cash
Common	07/19/2023	Restricted and Performance Stock Units	Issuer			10952	07/19/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THOMAS TAIRA 300 E. Rio Salado Parkway Tempe AZ 85281	Common	12/03/2025	25000	10000000.00
10b5-1 Sales for THOMAS TAIRA 300 E. Rio Salado Parkway Tempe AZ 85281	Common	11/28/2025	10000	3750126.00
10b5-1 Sales for THOMAS TAIRA 300 E. Rio Salado Parkway Tempe AZ 85281	Common	11/10/2025	952	309400.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted and performance stock units during the period of 07/19/2023 through 12/01/2025.
Date of Notice	12/08/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Thomas Taira
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)